GlassScriptPhysician profile
Matthew Alan Young
NPI 1457589327
$1,292.42
in general payments reported to CMS, 2019-2025
22 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $138 · 2021: $141 · 2022: $109 · 2023: $237 · 2024: $144 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $242.21 | 2019-2025 | Xtandi |
| Boston Scientific Corporation | $234.40 | 2019-2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous), Xpeeda Dsl Fiber |
| Sumitomo Pharma America, INC. | $83.49 | 2023-2025 | Orgovyx |
| Medtronic, INC. | $79.24 | 2023-2025 | Interstim |
| Abbvie INC. | $74.56 | 2019-2023 | Botox |
| Coloplast Corp | $69.91 | 2019-2025 | |
| Janssen Biotech, INC. | $62.90 | 2019-2025 | Erleada |
| Endo Pharmaceuticals INC. | $55.96 | 2020-2023 | Xiaflex |
| Intuitive Surgical, INC. | $50.00 | 2020 | |
| Laborie Medical Technologies Corp. | $47.78 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Antares Pharma, INC. | $35.62 | 2020-2025 | Xyosted |
| Urogen Pharma, INC. | $33.19 | 2025 | |
| Axonics, INC. | $30.64 | 2023 | Axonics |
| 180 Medical, INC. | $29.11 | 2025 | Gentlecath Glide |
| Srs Medical Systems, INC. | $26.97 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $25.92 | 2024 | Prolaris |
| Procept Biorobotics Corporation | $24.35 | 2025 | |
| Dendreon Pharmaceuticals LLC | $22.40 | 2020 | |
| Endo USA, INC. | $19.93 | 2025 | Xiaflex |
| Tolmar Pharmaceuticals, INC. | $15.53 | 2019 | |
| Merck Sharp & Dohme LLC | $14.20 | 2019 | |
| Medtronic USA, INC. | $14.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.